MDT

81.38

-1.36%↓

VEEV

209.53

-2.83%↓

A

99.53

-2.76%↓

WBA

10.84

-0.37%↓

CHE

563.06

-2.85%↓

MDT

81.38

-1.36%↓

VEEV

209.53

-2.83%↓

A

99.53

-2.76%↓

WBA

10.84

-0.37%↓

CHE

563.06

-2.85%↓

MDT

81.38

-1.36%↓

VEEV

209.53

-2.83%↓

A

99.53

-2.76%↓

WBA

10.84

-0.37%↓

CHE

563.06

-2.85%↓

MDT

81.38

-1.36%↓

VEEV

209.53

-2.83%↓

A

99.53

-2.76%↓

WBA

10.84

-0.37%↓

CHE

563.06

-2.85%↓

MDT

81.38

-1.36%↓

VEEV

209.53

-2.83%↓

A

99.53

-2.76%↓

WBA

10.84

-0.37%↓

CHE

563.06

-2.85%↓

Search

Alkermes PLC

Abrir

SetorSaúde

27.43 1.22

Visão Geral

Variação de preço das ações

24h

Atual

Mín

26.6

Máximo

27.74

Indicadores-chave

By Trading Economics

Rendimento

54M

147M

Vendas

52M

430M

P/E

Médio do Setor

12.518

59.668

EPS

1.05

Margem de lucro

34.072

Funcionários

1,800

EBITDA

58M

181M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+44.7% upside

Dividendos

By Dow Jones

Próximos Ganhos

1 de mai. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-562M

4.5B

Abertura anterior

26.21

Fecho anterior

27.43

Sentimento de Notícias

By Acuity

50%

50%

144 / 385 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bearish Evidence

Alkermes PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

19 de abr. de 2025, 01:45 UTC

Ganhos

Preview -- Barron's

18 de abr. de 2025, 15:57 UTC

Grandes Movimentos do Mercado

Eli Lilly CEO Ricks Warns Against Unintentionally Raising Prices as Weight-Loss Pill Nears Market Launch

20 de abr. de 2025, 22:32 UTC

Principais Notícias

Stocks Poised for Lower Open -- Barrons.com

20 de abr. de 2025, 18:43 UTC

Principais Notícias

Chicago Fed's Goolsbee Has a Warning About Independence -- Barrons.com

20 de abr. de 2025, 18:00 UTC

Principais Notícias

Tesla, Alphabet, Verizon, Chipotle, IBM, Boeing, and Many More Stocks to Watch This Week -- Barrons.com

20 de abr. de 2025, 13:00 UTC

Principais Notícias

Airbus Promised a Green Aircraft. That Bet Is Now Unraveling. -- WSJ

20 de abr. de 2025, 06:00 UTC

Principais Notícias

Foreign Stocks Are Beating the U.S. Market. Here's How Much You Should Have in Your Portfolio. -- Barrons.com

20 de abr. de 2025, 03:00 UTC

Principais Notícias

Putin's War Economy Can't Escape Trump's Trade Blitz -- WSJ

20 de abr. de 2025, 02:00 UTC

Principais Notícias

Who Will Pay the Price for Trump's Economic Goals? -- WSJ

19 de abr. de 2025, 02:00 UTC

Principais Notícias

Tomatoes Become One of the First Everyday Casualties of Trade War -- WSJ

19 de abr. de 2025, 02:00 UTC

Principais Notícias

Beijing Stokes Patriotic Fervor and Blames U.S. for Trade War -- WSJ

18 de abr. de 2025, 20:42 UTC

Aquisições, Fusões, Aquisições de Empresas

What Bill Ackman Sees in Hertz and Why He's Betting Big on the Rental-Car Company -- Barrons.com

18 de abr. de 2025, 20:32 UTC

Principais Notícias

Trump to Replace Acting IRS Commissioner -- 2nd Update

18 de abr. de 2025, 20:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

18 de abr. de 2025, 19:52 UTC

Conversa de Mercado

Correction to Aluminum Fee Rising Slower Than Forecast Article

18 de abr. de 2025, 19:40 UTC

Conversa de Mercado

Market Talk Roundup: Latest on U.S. Politics

18 de abr. de 2025, 19:40 UTC

Conversa de Mercado

Aluminum Fee Rising Slower Than Forecast From Tariff -- Market Talk

18 de abr. de 2025, 18:51 UTC

Ganhos

Netflix Has Made Several Risky Bets. Earnings Show They've Paid Off. -- Barrons.com

18 de abr. de 2025, 18:40 UTC

Aquisições, Fusões, Aquisições de Empresas

What Bill Ackman Sees in Hertz and Why He's Betting Big on the Rental-Car Company -- Barrons.com

18 de abr. de 2025, 18:29 UTC

Conversa de Mercado

Shorter Duration Seen as Way to Shield Portfolio From Political Turbulence -- Market Talk

18 de abr. de 2025, 18:21 UTC

Principais Notícias

Ford Halts Shipments of F-150s and Other Models to China -- WSJ

18 de abr. de 2025, 17:31 UTC

Principais Notícias

Trump to Replace Acting IRS Commissioner -- WSJ

18 de abr. de 2025, 17:24 UTC

Aquisições, Fusões, Aquisições de Empresas

Capital One's Discover Takeover Gets the Green Light. The Two Will Create the 6th-Largest U.S. Bank. -- Barrons.com

18 de abr. de 2025, 17:22 UTC

Aquisições, Fusões, Aquisições de Empresas

Capital One's $35 Billion Discover Takeover Clears Final Approvals -- Barrons.com

18 de abr. de 2025, 16:00 UTC

Principais Notícias

Trump's Trade War Threatens One of America's Top Energy Exports -- WSJ

18 de abr. de 2025, 15:53 UTC

Principais Notícias
Aquisições, Fusões, Aquisições de Empresas

Bill Ackman Teases Prospect of Uber, Hertz Partnership -- Update

18 de abr. de 2025, 15:46 UTC

Ganhos

Tech's Problems in China Are Getting Worse. These Companies Are Most at Risk. -- Barrons.com

18 de abr. de 2025, 15:10 UTC

Conversa de Mercado
Ganhos

Netflix Momentum Likely To Continue Thanks To Growing Subscriber Base -- Market Talk

18 de abr. de 2025, 14:46 UTC

Ganhos

Tech Earnings Have Good News for Chip Stocks, So Far. And 1 Warning. -- Barrons.com

18 de abr. de 2025, 14:24 UTC

Conversa de Mercado
Ganhos

Netflix Still Has Room to Add Subscribers -- Market Talk

Comparação entre Pares

Variação de preço

Alkermes PLC Previsão

Preço-alvo

By TipRanks

44.7% parte superior

Previsão para 12 meses

Média 39.07 USD  44.7%

Máximo 52 USD

Mínimo 30 USD

Com base em 14 analistas de Wall Street que oferecem metas de preço de 12 meses para Alkermes PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

14 ratings

8

Comprar

6

Manter

0

Vender

Pontuação Técnica

By Trading Central

26.98 / 27.04Suporte e Resistência

Curto Prazo

Weak Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Weak Bearish Evidence

Sentimento

By Acuity

144 / 385 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Alkermes PLC

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS). The Company's products include ARISTADA, VIVITROL, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, TREVICTA, RISPERDAL CONSTA, AMPYRA, FAMPYRA, BYDUREON, Aripiprazole lauroxil, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, ALKS 4230 and ALKS 7119. The Company's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.